Mobilization and Elimination of FLT3-ITD+ Acute Myelogenous Leukemia (AML) Stem/Progenitor Cells by Plerixafor/G-CSF/Sorafenib : Results from a Phase I Trial in Relapsed/Refractory AML Patients
The animal protocol was approved by the Collaborative Institutional Training Initiative (CITI) Animal Care and Use Working Group
Multifunctional nanoparticles for genetic engineering and bioimaging of natural killer (NK) cell therapeutics
BPC-157 is known as the healing peptide, repairing the gut, muscles, and joints to keep your body strong and balanced
Effects of growth hormone in patients with tibial fracture: a randomised, double-blind, placebo-controlled clinical trial
Subsequently, rhIGF-1 was applied to treat the injured site, and functional and biomechanical data were collected